Editas Medicine, Inc. (LON:0IFK)
1.911
-0.380 (-16.59%)
At close: Feb 21, 2025
Editas Medicine Employees
Editas Medicine had 265 employees as of December 31, 2023. The number of employees increased by 39 or 17.26% compared to the previous year.
Employees
265
Change (1Y)
39
Growth (1Y)
17.26%
Revenue / Employee
173.88K GBP
Profits / Employee
-592.86K GBP
Market Cap
125.38M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
Hikma Pharmaceuticals | 9,100 |
ConvaTec Group | 10,136 |
HUTCHMED (China) | 1,988 |
Genus | 3,500 |
Editas Medicine News
- 5 weeks ago - Editas And Intellia: Strategic Shifts And Long-Term Investment Potential - Seeking Alpha
- 5 weeks ago - CRISPR Therapeutics: Unfairly Punished By The Issues Of Its Peers - Seeking Alpha
- 5 weeks ago - Editas Medicine, Inc. (EDIT) 43rd Annual JPMorgan Healthcare Conference - (Transcript) - Seeking Alpha
- 5 weeks ago - Editas Medicine Highlights New In Vivo Preclinical Proof of Concept Data, Anticipated 2025 Key Milestones, and Three-year Strategic Priorities - GlobeNewsWire
- 6 weeks ago - Editas Medicine to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - JPMorgan Downgrades Editas Medicine, Says Focus Shift Sparks Investor Caution - Benzinga
- 2 months ago - Editas Medicine Reshapes Future with In Vivo Focus Amid Major Workforce Cuts - GuruFocus
- 2 months ago - This Toll Brothers Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Benzinga